📄 Cross-examination of Collin Yamauchi (part 3) — Friday, May 26, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\26\CROSS-EXAMINATION-OF-COLLIN-YA.DOC
TRIAL
▲ Day 83 of 167

Cross-examination of Collin Yamauchi (part 3)

Witness: Collin Yamauchi
Examiner: Barry Scheck
Called by: Prosecution • Date: Friday, May 26, 1995 • Utterances: 605
Defense attorney Barry Scheck cross-examined LAPD DNA analyst Collin Yamauchi, methodically attacking his training, proficiency testing practices, and the rush under which he performed DNA analysis on June 14-15, 1994. Scheck established that Yamauchi was not the lab's most experienced DNA analyst, that proficiency tests were not truly blind (analysts could read each other's results), and that Yamauchi processed 23 samples in a single day despite the Amplitype user guide recommending a limit of approximately 15 to reduce contamination and mix-up risk.
1 THE COURT:

Thank you, ladies and gentlemen. Please be seated. Mr. Yamauchi, would you resume the witness stand, please. Let the record reflect that we've been rejoined by all the members of our jury panel. And, Mr. Scheck, you may continue with your cross-examination.

2 MR. SCHECK:

Thank you, your Honor.

3 MR. SCHECK:

Mr. Yamauchi, you remember at the very beginning of our discussion here, I asked you about whether your protocol indicated that each analyst must have, at a minimum, forensic DNA laboratory experience, including successful analysis of a typical range of forensic samples, and that this normally takes six months? Remember I asked you that question?

4 MR. HARMON:

Objection. That misstates the question.

5 THE COURT:

It's close enough.

6 MR. YAMAUCHI:

I recall something like that.

7 MR. SCHECK:

And you said that you needed to see the protocol, right?

8 MR. YAMAUCHI:

Yes.

9 MR. HARMON:

Can I see that?

10 MR. SCHECK:

Sure.

11 (Brief pause.)
12 MR. SCHECK:

Let me show you this document, see if it refreshes your recollection. And I'm--please, why don't you take a look at the--save time--the paragraph that I've marked for you.

13 MR. YAMAUCHI:

Can I look at the pages before and after that?

14 MR. SCHECK:

Look all you want.

15 MR. YAMAUCHI:

Thank you.

16 THE COURT:

Mr. Scheck, that kind of gesture is not required.

17 MR. SCHECK:

Oh, I'm sorry.

18 (Brief pause.)
19 MR. YAMAUCHI:

Okay.

20 MR. SCHECK:

All right. So having refreshed your recollection by looking at that document, do you not agree that your protocol says that at a minimum, an analyst must have forensic DNA laboratory experience including the successful analysis of a typical range of forensic samples, and that this normally takes six months?

21 MR. YAMAUCHI:

Well, you left out the word "Approximately six months." You left out the word "Approximately."

22 MR. SCHECK:

When I read it to you the first time, did I leave out "Approximately six months"?

23 MR. YAMAUCHI:

Yes, and you did it again just now.

24 MR. SCHECK:

Okay. So in other words, the reason that you did not recall this provision is that you think I left out the word "Approximately" and you were conscious of that?

25 MR. HARMON:

Objection. It's argumentative.

26 THE COURT:

Sustained.

27 MR. SCHECK:

Was the reason you didn't answer my question before in terms of being able to recall this provision of the protocol is that you thought I left out the word "Approximately"?

28 MR. YAMAUCHI:

Well, I heard it right now and I'm reading it. So I'm comfortable with what I see.

29 MR. SCHECK:

Okay. So the first time I read it, you think I left out the word "Approximately," and that's why you didn't remember it?

30 MR. YAMAUCHI:

Yes, I believe you did.

31 MR. SCHECK:

Okay. My apologies if that's true. And you were conscious of that; is that right?

32 MR. YAMAUCHI:

Yes.

33 MR. SCHECK:

And why--did you have--well, did you have six months of forensic DNA laboratory experience, including the successful analysis of a typical range of forensic samples, before you started to do casework?

34 MR. YAMAUCHI:

Yes. Approximately.

35 MR. SCHECK:

Well, let's try six months. Did you have six months?

36 MR. HARMON:

Objection. It's vague.

37 THE COURT:

Overruled.

38 MR. YAMAUCHI:

I'm not sure exactly how much. It's approximately six months. I would have to go back to the records and check exactly how much time I did spend to do all my proficiencies and my validations.

39 MR. SCHECK:

So what you're telling us is, you don't know if you spent six months actually doing hands-on work in validation training before you started to do casework. Is that what you're saying?

40 MR. YAMAUCHI:

Once again, it's approximately six months. It's around that time--time period.

41 MR. SCHECK:

Now, you mentioned on direct examination external proficiency tests.

42 MR. YAMAUCHI:

Yes.

43 MR. SCHECK:

And these are the tests where you know you're being tested?

44 MR. YAMAUCHI:

Yes.

45 MR. SCHECK:

How many external proficiency tests did you do before you did the work in this case?

46 MR. YAMAUCHI:

That's another thing I would have to check records on. I don't have that information memorized and it's quite a while ago, but I know I did more than one.

47 MR. SCHECK:

You're sure of that?

48 MR. YAMAUCHI:

Yes.

49 MR. SCHECK:

Now, when you say "Did," you mean you actually performed the work on them?

50 MR. YAMAUCHI:

Yes. I would have analyzed the samples given to me by my supervisor.

51 MR. SCHECK:

Do you--when you did the work in this case, did you know--had you been graded, did you know the results of both of these proficiency tests?

52 MR. YAMAUCHI:

I don't understand. Did I know the results as to time frame before or after? What do your--what's your question?

53 MR. SCHECK:

Let's try it this way. Did you receive an external proficiency test in November of 1993?

54 MR. YAMAUCHI:

I'd have to check the records.

55 MR. SCHECK:

All right. Did you receive a proficiency test in March of 1994?

56 MR. YAMAUCHI:

Possibly. I'd have to check the records to be sure though.

57 MR. SCHECK:

All right. And when you get a proficiency test, you do the typings, and then at some point down the line, you're told how you did?

58 MR. YAMAUCHI:

Yes.

59 MR. SCHECK:

So my question to you is, how many proficiency tests did you both do and get graded on before you did the work in this case?

60 MR. YAMAUCHI:

Okay. To give you a fair and as accurate an answer as possible, I would have to go back to the records and look that up for sure.

61 MR. SCHECK:

Okay. Now, in taking--your recollection is that you think you took about two external proficiency tests before you did the work in this case?

62 MR. YAMAUCHI:

No. I said at least one.

63 MR. SCHECK:

At least one. Okay. In this test that you did, did you get a set of samples and Erin Reilly get a set of samples?

64 MR. HARMON:

Objection. Calls for speculation, hearsay, no foundation.

65 THE COURT:

Overruled. Overruled.

66 MR. YAMAUCHI:

Yes. We generally get each a set.

67 MR. SCHECK:

Uh-huh. Now, just so we're clear, what happens is is that the test provider gives you a set of samples and then you then test them, correct?

68 MR. YAMAUCHI:

That's correct.

69 MR. SCHECK:

Okay. Now, did you hear any of Gary Sims' testimony about the way these kinds of tests were handled at the Department of Justice?

70 MR. YAMAUCHI:

I might have--I listened to bits and pieces of his testimony, but not much.

71 MR. SCHECK:

Well, when this kind of proficiency test is given to the laboratory and two different analysts in the lab are performing the test--are you with me?

72 MR. YAMAUCHI:

Yes.

73 MR. SCHECK:

All right. In this case, a set of proficiency samples was sent to LAPD, and you performed the test and Erin Reilly performed the test?

74 MR. YAMAUCHI:

Yes.

75 MR. SCHECK:

Okay. Did Harry Klan, another one of your analysts, perform the test?

76 MR. YAMAUCHI:

When he was on line and ready to test samples, yes, he would. He would do it that way. We would all get our sets.

77 MR. SCHECK:

Okay. Now, in terms of the tests that you performed before you did the work in this case, at that point in time, it would be just you and Erin Reilly?

78 MR. YAMAUCHI:

Yes.

79 MR. SCHECK:

And when each of you got the samples, did you know what the other person's results were before you reported your results?

80 MR. YAMAUCHI:

No.

81 MR. SCHECK:

Well--and that's the way it should be done?

82 MR. YAMAUCHI:

We shouldn't corroborate. I don't think that's right.

83 MR. SCHECK:

Uh-huh. So in other words, if Erin Reilly performed the test and got some typings, it would be improper on a proficiency test for you to be the second reader to look at her results and confirm them if you were also going to be performing the test?

84 MR. HARMON:

Objection. It's argumentative, irrelevant.

85 THE COURT:

Sustained.

86 MR. SCHECK:

All right. Let's be clear. When you take one of these samples, you would do some typing, correct?

87 MR. YAMAUCHI:

Yes.

88 MR. SCHECK:

And you create one of these hybridization records?

89 MR. YAMAUCHI:

Yes.

90 MR. SCHECK:

Where you put a picture of the strip on the top of the page and then you write down on the bottom of the page what the results are?

91 MR. YAMAUCHI:

Yes.

92 MR. SCHECK:

And at the top of the page, there's a little box for analyst?

93 MR. YAMAUCHI:

Yes.

94 MR. SCHECK:

And when you write in your initials at the top for analyst, that means you're the one that did the typing?

95 MR. YAMAUCHI:

Yes.

96 MR. SCHECK:

And when there's another box there for confirming analyst, if you write your initials in there, that means that the person whose initials are there is the one that does the second reading?

97 MR. YAMAUCHI:

Yes.

98 MR. SCHECK:

Now, in the proficiency tests that you received, did Erin Reilly do the typing and then you were the confirming analyst to look at the results? Did that happen?

99 MR. YAMAUCHI:

I might have been. It would be either myself or Greg.

100 MR. SCHECK:

Well, if you're the confirming analyst, when she's doing the typing on the proficiency test, doesn't that mean that you're knowing what answers she's getting?

101 MR. HARMON:

Objection. It's irrelevant, argumentative.

102 THE COURT:

It's argumentative. Why don't you rephrase the question.

103 MR. SCHECK:

All right.

104 MR. SCHECK:

If she does the typing and then you look at the results as the confirming analyst, that means you know what her results are?

105 MR. HARMON:

Objection. That's speculative, no foundation, calls for conclusion.

106 THE COURT:

Overruled.

107 MR. YAMAUCHI:

Yes. Provided I know that she's doing those--those samples. In other words, what I do is, I look at the picture of her strips, and then I confirm that the typings that she put for each of those strips is what I would call. That's what I do for confirmation.

108 MR. SCHECK:

Right. So you look at the strips and you see if you agree with her reading of the typing strip, correct?

109 MR. YAMAUCHI:

Yes.

110 MR. SCHECK:

And these samples in their description box will indicate something like cap, sample, correct?

111 MR. YAMAUCHI:

I'm not sure how she writes it in, but she could write it in like that.

112 MR. SCHECK:

And--

113 (Brief pause.)
114 MR. SCHECK:

Ask this page be marked as--

115 THE COURT:

1182.

116 (Deft's 1182 for id = one-page document)
117 MR. HARMON:

Could I see that, your Honor?

118 MR. SCHECK:

I'm sorry.

119 (Brief pause.)
120 MR. SCHECK:

Now, do you recognize 1182 as being the kind of hybridization record that you would use in a proficiency test, your laboratory?

121 MR. YAMAUCHI:

Yes.

122 MR. SCHECK:

All right. And in the description box, there's an indication that a sample is called cap, right?

123 MR. YAMAUCHI:

Yes.

124 MR. SCHECK:

And that means that it's College of American Pathologists?

125 MR. YAMAUCHI:

Yes.

126 MR. SCHECK:

And that would indicate to you or to anyone looking at it that that is a sample from a College of American Pathologists proficiency test?

127 MR. YAMAUCHI:

Well, that's what I wrote in there, yes.

128 MR. SCHECK:

And that's your initial on the top of 1182?

129 MR. YAMAUCHI:

Yes. I'm the analyst. This is--this would be my set of samples I would assume.

130 MR. SCHECK:

And who's the confirming analyst?

131 MR. YAMAUCHI:

Looks likes Erin Reilly.

132 MR. SCHECK:

So in this instance, you would be doing the test and Erin Reilly would be reading your strips to see if you got the right answers?

133 MR. YAMAUCHI:

Yes.

134 MR. SCHECK:

So you would be looking at each other's strips on the same test that both of you were taking?

135 MR. HARMON:

Objection. Assumes facts not in evidence.

136 THE COURT:

Sustained.

137 MR. SCHECK:

Did that happen?

138 MR. HARMON:

Objection. That's vague.

139 THE COURT:

Overruled.

140 MR. YAMAUCHI:

Well, in this instance, I might have done the test--she might have done the test already and submitted her results. But I mean, I could very well have. I would have to see the sheets and how she marks her--her proficiency samples on there.

141 MR. SCHECK:

Could it have happened that in one of these tests, she did the test and then you were the confirming analyst for her?

142 MR. HARMON:

Objection. Vague, calls for speculation, no foundation.

143 THE COURT:

Overruled.

144 MR. YAMAUCHI:

That's possible.

145 MR. SCHECK:

And if that occurred, wouldn't that mean that you would be knowing what her results were before you did the test?

146 MR. HARMON:

Objection. Vague, calls for speculation, no foundation.

147 THE COURT:

Overruled.

148 MR. YAMAUCHI:

Yes. That's possible, if she wrote in the corresponding numbers and everything like that and I took note of it.

149 MR. SCHECK:

Now, the term--are you familiar with the term "Blind means" in terms of scientific testing?

150 MR. YAMAUCHI:

Yes. Like without knowing?

151 MR. SCHECK:

Right. Without knowing the answers.

152 MR. YAMAUCHI:

Yes.

153 MR. SCHECK:

All right. So it would be fair to say that you're not blinded to the answers when you take a proficiency test if you've already read strips from another analyst in your laboratory who took the same test?

154 MR. YAMAUCHI:

Provided I saw that and I did confirm her strips.

155 MR. SCHECK:

Uh-huh. Now, you have never taken in your laboratory an external blind proficiency test, have you?

156 MR. YAMAUCHI:

Okay. Could you please define that?

157 MR. SCHECK:

Okay. You don't--you've never heard the term "External blind proficiency test"?

158 MR. YAMAUCHI:

Yes, but I want to know if we're on the same wavelength.

159 MR. SCHECK:

All right. How would you define an external blind proficiency test?

160 MR. YAMAUCHI:

Well, maybe if you'd just define it, we can move along.

161 MR. SCHECK:

Well, I'm first interested in--have you been watching the testimony of the trial?

162 THE COURT:

Excuse me. Excuse me. Excuse me. Excuse me. Excuse me.

163 MR. SCHECK:

I'm sorry.

164 THE COURT:

This is not an audience participation enterprise here, folks. You're here as an audience, not as participants. If I hear another outburst from the audience, I'm clearing the courtroom. There's nothing funny about this. Mr. Scheck.

165 MR. SCHECK:

Thank you, your Honor.

166 MR. SCHECK:

What's your understanding of an external blind proficiency test, Mr. Yamauchi?

167 MR. YAMAUCHI:

It's done from a source outside of the laboratory in question and it's done in such a way that the laboratory doesn't know the results.

168 MR. SCHECK:

But they know they're being tested?

169 MR. YAMAUCHI:

Yes.

170 MR. SCHECK:

Then what's your--what is your definition of an open external proficiency test?

171 MR. YAMAUCHI:

Open external. I don't know what that means.

172 MR. SCHECK:

Never heard that expression?

173 MR. YAMAUCHI:

No, I haven't.

174 MR. SCHECK:

Did you watch Dr. Cotton testify at all?

175 MR. YAMAUCHI:

Bits and pieces.

176 MR. SCHECK:

All right. Mr. Sims?

177 MR. YAMAUCHI:

Again, bits and pieces.

178 MR. SCHECK:

Have you ever heard anyone define an open external proficiency test as a test where the samples are submitted from an external source, but the analysts at the laboratory know that it's a test?

179 MR. YAMAUCHI:

That's what I just described, isn't it? They're--it's done by an outside source and they don't know the results. Isn't that what I said?

180 MR. SCHECK:

That's how you define an external blind test, right?

181 MR. YAMAUCHI:

Right.

182 MR. SCHECK:

Wouldn't an external blind proficiency test be one where the samples are submitted by an external source, but the laboratory doesn't know it's a test, they think it's a real case?

183 MR. YAMAUCHI:

I understand that to be a double blind.

184 MR. SCHECK:

That's how you define double blind?

185 MR. YAMAUCHI:

Yes.

186 MR. SCHECK:

All right. You've never heard anybody refer to such a test as an external blind?

187 MR. YAMAUCHI:

External blind is the way I just explained it.

188 MR. SCHECK:

Right. And you've never heard anybody--you've never heard of an--an open external test? That definition you've never heard of?

189 MR. YAMAUCHI:

No.

190 MR. HARMON:

Objection. Calls for hearsay. It's irrelevant.

191 THE COURT:

Overruled.

192 MR. SCHECK:

Now, using your phrase then, have you ever in your laboratory, you or any other analyst ever done a double blind external proficiency test?

193 MR. YAMAUCHI:

No.

194 MR. SCHECK:

Mr. Yamauchi, have you ever read the report of the national research council entitled DNA technology in forensic science?

195 MR. YAMAUCHI:

Yes I have. I'm familiar with that.

196 MR. SCHECK:

Have you read it cover to cover?

197 MR. YAMAUCHI:

Maybe not cover to cover.

198 MR. SCHECK:

Have you studied it?

199 MR. YAMAUCHI:

Well, certain areas I've read numerous times.

200 MR. SCHECK:

Which areas?

201 MR. HARMON:

Objection. That's irrelevant, your Honor.

202 THE COURT:

Sustained. Why don't you focus on a particular area, counsel.

203 MR. SCHECK:

All right.

204 THE COURT:

Let's move this along.

205 MR. SCHECK:

Are you familiar with the section of the national research council report at page 88 concerning laboratory error rates?

206 MR. YAMAUCHI:

I'm really not familiar with this area because generally speaking, that was supposed to be or have to do with the RFLP testing.

207 MR. SCHECK:

So you didn't read that section of the NRC report because you think that the section on laboratory error rates only concerned RFLP testing?

208 MR. HARMON:

Objection, your Honor. It's argumentative.

209 THE COURT:

Overruled.

210 MR. YAMAUCHI:

No. I've read this, but I'm not--like I haven't studied it.

211 MR. SCHECK:

All right. So have you read it--are you sufficiently familiar with it so that you can tell us whether or not you have relied upon it in forming your opinions with respect to forensic DNA typing in your testimony in this case?

212 MR. HARMON:

Objection. That's vague, compound.

213 THE COURT:

It's vague.

214 MR. SCHECK:

All right. Do you rely on that section, the NRC report concerning laboratory error rates, in forming your opinions about forensic DNA typing?

215 MR. HARMON:

Objection. That's vague.

216 THE COURT:

Overruled.

217 MR. YAMAUCHI:

No.

218 MR. SCHECK:

Is there any portion of the NRC report that you rely upon in forming your opinions about forensic DNA typing?

219 MR. HARMON:

Objection. That's vague.

220 THE COURT:

Sustained.

221 MR. SCHECK:

Mr. Harmon asked you on direct examination if you keep abreast of the scientific literature in the field of DNA testing. Do you recall that?

222 MR. YAMAUCHI:

Yes.

223 MR. SCHECK:

And he asked you which journals that you read regularly. Do you recall that?

224 MR. YAMAUCHI:

Yes.

225 MR. SCHECK:

And at that time, you couldn't really remember which journals you regularly read?

226 MR. YAMAUCHI:

Well, I read the ones that are--having to do with PCR technology.

227 MR. SCHECK:

All right. Do you read the journal--American Journal of Human Genetics?

228 MR. YAMAUCHI:

I believe I read an article out of there directly related, PCR technology.

229 MR. SCHECK:

But is that a journal that you read with some regularity to keep up with--

230 MR. YAMAUCHI:

All the periodicals? No, I don't.

231 MR. SCHECK:

All right. Do you--are you a regular reader of the scientific journal nature?

232 MR. YAMAUCHI:

I read articles out of there.

233 MR. SCHECK:

Do you read that regularly?

234 MR. YAMAUCHI:

No, not on a regular basis.

235 MR. SCHECK:

Are you a regular reader of the scientific journal known as science?

236 MR. YAMAUCHI:

I've read articles out of there too.

237 MR. SCHECK:

Do you read that regularly?

238 MR. YAMAUCHI:

No, I don't.

239 (Discussion held off the record between Defense attorneys.)
240 MR. SCHECK:

Are you familiar with an organization called the American Academy of Sciences?

241 MR. YAMAUCHI:

Yes.

242 MR. SCHECK:

And if you join that organization, don't you get a regular subscription to the journal science?

243 MR. HARMON:

Objection. That's irrelevant, your Honor.

244 THE COURT:

Overruled.

245 MR. YAMAUCHI:

No, I'm not a member.

246 MR. SCHECK:

Okay. Now, in your training--withdrawn. Have you ever read the report of the California association of crime lab directors concerning proficiency tests that they ran in 1988 and 1989 on forensic DNA laboratories?

247 MR. YAMAUCHI:

The CACLD?

248 MR. SCHECK:

Yes. The CACLD study that involved open or involved proficiency tests, external proficiency tests for laboratories; namely cellmark, live codes, forensic science associates in 1988, 1989 and reports were published in years subsequent to that. Did you read any of those reports?

249 MR. YAMAUCHI:

Something like that sounds familiar. I'd like to see that though if you have a copy.

250 MR. SCHECK:

Well, do you recall reading anything, reading any of those reports at any time during the course of your training?

251 MR. YAMAUCHI:

I'd have to see a copy to refresh my memory, if you have one.

252 MR. SCHECK:

In the course of your training, did you read anything or were you told anything about how cellmark got two false positives in the CACLD tests?

253 MR. HARMON:

Objection. Calls for hearsay. It's irrelevant.

254 THE COURT:

Sustained.

255 MR. SCHECK:

You testified on direct examination that you attend California Association of Criminalists meetings.

256 MR. YAMAUCHI:

Yes.

257 MR. SCHECK:

At the C--that's known as the CAC?

258 MR. YAMAUCHI:

Yes.

259 MR. SCHECK:

At CAC meetings, have you ever participated in any discussions about how false positives occurred on the CACLD tests for cellmark and forensic science associates?

260 MR. HARMON:

Objection. Calls for hearsay.

261 MR. SCHECK:

Just whether he--

262 THE COURT:

Sustained. It's irrelevant.

263 MR. SCHECK:

During the course of your training, were you ever--did you ever have any discussion or lectures about how false positives can occur at forensic DNA laboratories?

264 MR. YAMAUCHI:

Yes.

265 MR. SCHECK:

Did you endeavor to study how false positives can occur at forensic DNA laboratories?

266 MR. YAMAUCHI:

To study it, well, it's all a part of your training. I mean, you have to know what causes a positive result and what doesn't and what makes it valid and what makes it questionable. Of course. That's very important.

267 MR. SCHECK:

Very important. And in the course of pursuing this very important question, did you endeavor to find out how cellmark got two false positives in the CACLD tests?

268 MR. HARMON:

Objection. It's irrelevant.

269 THE COURT:

Sustained. It's a different technology, counsel.

270 MR. SCHECK:

Did you endeavor to find out how--forensic science associates is a laboratory that does PCR testing?

271 MR. YAMAUCHI:

Yes.

272 MR. SCHECK:

Did you endeavor to find out how forensic science associates got a false positive in the CACLD tests?

273 MR. HARMON:

Objection. That's irrelevant.

274 THE COURT:

Overruled.

275 MR. YAMAUCHI:

No, I didn't endeavor to find that out.

276 MR. SCHECK:

But you agree that finding out how false positives occur is very important?

277 MR. YAMAUCHI:

Certainly. When you're learning about the theoretical as well as the practical applications of PCR technology, you have to study these things.

278 MR. SCHECK:

And you were aware during your training period that there had been a false positive on the CACLD tests for forensic science associates, a lab that uses PCR technology?

279 MR. HARMON:

Objection. Irrelevant, calls for hearsay.

280 THE COURT:

Sustained.

281 MR. SCHECK:

Were you aware of that?

282 MR. YAMAUCHI:

No.

283 MR. HARMON:

Same objection.

284 THE COURT:

No.

285 MR. SCHECK:

So you weren't even aware of it during your training period?

286 MR. YAMAUCHI:

No.

287 MR. SCHECK:

And your training period was in 1993?

288 MR. YAMAUCHI:

Yes.

289 MR. SCHECK:

And you did not endeavor to find out about the testing of CACLD and what results occurred, those tests occurring in 1988 and `89?

290 MR. YAMAUCHI:

Once again, what you're referring to sounds familiar. I'd like to look at the article directly pertaining to that to refresh my memory.

291 MR. SCHECK:

Did you hear Dr. Cotton testify about how false positives occurred at cellmark during the CACLD tests?

292 MR. HARMON:

Objection.

293 MR. SCHECK:

Did you hear that testimony in this courtroom?

294 MR. HARMON:

Irrelevant, calls for hearsay.

295 THE COURT:

Sustained. Sustained.

296 MR. SCHECK:

In terms of your training about false positives occurring in a DNA laboratory, was there discussion about degraded samples being analyzed in the same place during the same period as the reference sample of a suspect?

297 MR. HARMON:

Objection. Calls for hearsay.

298 THE COURT:

Overruled. Was that part of your training?

299 MR. YAMAUCHI:

In the same area--

300 MR. SCHECK:

During the same period.

301 MR. HARMON:

Objection. That's compound, your Honor.

302 THE COURT:

Well, it's vague is what it is. Why don't you go ahead and restate the question.

303 MR. SCHECK:

Did you receive any training with respect to false positives occurring with degraded samples being analyzed along with the reference sample of a suspect?

304 MR. HARMON:

Objection. "Along with" is vague, your Honor.

305 THE COURT:

Overruled.

306 MR. YAMAUCHI:

A degraded sample--how--how would you know a sample is degraded if it's unknown or--you know, or do you know that it's a degraded sample? I don't--I'm not understanding your question fully. Do you take a--do you take something and do you degrade it?

307 MR. SCHECK:

You don't understand my question?

308 MR. YAMAUCHI:

No, I don't.

309 MR. SCHECK:

Let me try to reformulate my question. Did you receive any training about false positives arising when samples that are degraded are analyzed--are examined, analyzed, cut along with blood in a reference tube from a suspect?

310 MR. YAMAUCHI:

No, I never did.

311 MR. SCHECK:

And in that vague recollection you have--

312 THE COURT:

Counsel, start again.

313 MR. SCHECK:

All right. You told us that you had a vague recollection of how false positives occurred during the CACLD study.

314 MR. YAMAUCHI:

Yes. I like to reference that.

315 MR. SCHECK:

And in terms of the recollections that you have now, did any of it involve a laboratory handling degraded samples along with the reference sample of a suspect?

316 MR. HARMON:

Objection. "Along with" is vague and "Handling" is vague.

317 THE COURT:

Sustained.

318 MR. SCHECK:

When you did your proficiency tests, these external proficiency tests, did you have someone in the room witnessing each transfer of material?

319 MR. YAMAUCHI:

Witnessing me do my work? No.

320 MR. SCHECK:

In other words, actually writing down what samples you put at what tubes and what time.

321 MR. YAMAUCHI:

No.

322 MR. SCHECK:

Did you hear Dr. Cotton's testimony that during the CACLD proficiency test where they got a false positive, that there was actually a witness in the room looking at the transfer of materials and witnessing it?

323 MR. HARMON:

Objection. It's irrelevant, calls for hearsay.

324 THE COURT:

Sustained.

325 MR. SCHECK:

Were you told in your training that forensic DNA typing procedures are delicate?

326 MR. YAMAUCHI:

I might have heard that word, but if you were more specific, maybe I could help you out.

327 MR. SCHECK:

Were you told that it's easy to make a mistake and not be aware of it?

328 MR. YAMAUCHI:

No, I wasn't.

329 MR. SCHECK:

Were you told that other laboratories had made false positive mistakes and still can't figure out how it happened?

330 MR. HARMON:

Objection. Calls for hearsay.

331 THE COURT:

Sustained.

332 MR. SCHECK:

Were you told in your training that it's more important to be careful and reliable when doing DNA typing than to rush and make mistakes?

333 MR. HARMON:

Objection. It's vague, calls for hearsay.

334 THE COURT:

Overruled.

335 MR. YAMAUCHI:

I think that takes common sense. Anybody can see that.

336 MR. SCHECK:

Were you told that in your training?

337 MR. YAMAUCHI:

Specifically, I don't remember if I was told in those words.

338 MR. SCHECK:

Were you--

339 THE COURT:

Proceed.

340 MR. SCHECK:

One last question in this line. Were you told in your training that it is the job of a criminalist to be independent of the police and to resist pressure to rush analysis that would compromise your work?

341 MR. YAMAUCHI:

Again, that's a common-sense question. You never want to rush your work or do anything at all that could compromise the integrity of your work.

342 MR. SCHECK:

And was there discussion or emphasis in your training that it was important for criminalists to resist pressure from police to do work faster than the criminalists believes it can be safely and reliably done?

343 MR. HARMON:

Objection. Compound, irrelevant.

344 THE COURT:

It's compound. Rephrase the question.

345 MR. SCHECK:

Was there any emphasis in your training that it was important for a criminalist on occasion to resist pressure from police to do work in a rush?

346 THE COURT:

Isn't that the same question we asked a moment ago? You said you had one more question on that line. This is about three more.

347 MR. SCHECK:

Well, this is it.

348 MR. SCHECK:

Was that emphasized in your training?

349 MR. YAMAUCHI:

I think I just answered that.

350 MR. SCHECK:

And what's your--and your answer is, it's just common sense, but you don't recall anybody specifically stressing that?

351 MR. YAMAUCHI:

Well, Mr. Matheson would have told me that because he told me that for conventional testing, that not to let anybody rush you into doing something that you can't do.

352 MR. SCHECK:

Okay. On the afternoon of June 13th, Mr. Matheson chose you to do the DNA analysis in this case?

353 MR. YAMAUCHI:

13th? Yes.

354 MR. SCHECK:

But you were not the most experienced DNA in the lab.

355 MR. HARMON:

Objection. That's irrelevant.

356 THE COURT:

Overruled.

357 MR. YAMAUCHI:

Well, at that time, he didn't know whether it was just going to be a DNA case or whether it involved other aspects of conventional serology of which I had more experience.

358 MR. SCHECK:

My question to you, sir, was simply, you were not the most experienced DNA analyst in the lab, were you?

359 MR. YAMAUCHI:

No.

360 MR. SCHECK:

Thank you. Erin Reilly had more experience in doing PCR testing than you did?

361 MR. YAMAUCHI:

Yes, she did.

362 MR. SCHECK:

Harry Klan had more experience doing RFLP testing than you did?

363 MR. YAMAUCHI:

Yes, he did.

364 MR. SCHECK:

And on the afternoon of June 13th, when you were assigned to this case, you knew there was intense police interest in this matter?

365 MR. YAMAUCHI:

On when?

366 MR. SCHECK:

The afternoon of June 13th.

367 MR. YAMAUCHI:

13? Well, I know it was a high profile case and, you know, I really didn't have that much information at that point.

368 MR. SCHECK:

Uh-huh. So you didn't know at that point whether the District Attorney's office had an intense interest in this case?

369 MR. HARMON:

Objection. It's irrelevant, calls for speculation, hearsay.

370 THE COURT:

Sustained.

371 MR. SCHECK:

When you were assigned this case on the afternoon of June 13th, did you not feel that you had just been given a very big responsibility?

372 MR. HARMON:

Objection. That's irrelevant.

373 THE COURT:

Overruled.

374 MR. YAMAUCHI:

I wasn't sure how involved or important the serology was going to end up being because I didn't know anything about what was at the scenes or any specifics.

375 MR. SCHECK:

Well, you knew in your words that it was a high profile case?

376 MR. YAMAUCHI:

Building up to be one, yeah.

377 MR. SCHECK:

You knew that right away when you were first assigned to it?

378 MR. YAMAUCHI:

When Mr. Matheson asked me, yes.

379 MR. SCHECK:

And that made you nervous, didn't it?

380 MR. YAMAUCHI:

Well, not really because I didn't know what it was all going to entail.

381 MR. SCHECK:

All right. Now let's move to the morning of June 14th. Did you meet that morning with Mr. Matheson, Mr. Fung and Detective Lange any time that morning?

382 MR. HARMON:

Objection. That's compound.

383 THE COURT:

Sustained.

384 MR. SCHECK:

Did you attend a meeting at 7:00 o'clock in the morning with Detective Lange, Mr. Matheson and Mr. Fung?

385 MR. YAMAUCHI:

To my recollection, I remember talking to Greg in the morning.

386 MR. SCHECK:

You did not see Detective Lange at 7:00 o'clock in the morning with a pair of sneakers have a--be present during a conversation with him and Mr. Fung, Mr. Matheson?

387 MR. HARMON:

Objection. That calls for speculation.

388 THE COURT:

Rephrase the question.

389 MR. SCHECK:

Do you recall a meeting 7:00 o'clock or early in the morning of June 14th where Detective Lange was present?

390 MR. YAMAUCHI:

Detectives often come in and out of serology. I'm--I'm not sure if he was there or not.

391 MR. SCHECK:

Are you telling us, sir, that you have no recollection whatsoever of seeing Detective Lange in the SID laboratory on the morning of June 14th at any time?

392 MR. YAMAUCHI:

I'm telling you I just don't remember.

393 MR. SCHECK:

Don't remember him there with a pair of white sneakers?

394 MR. HARMON:

Objection. Asked and answered.

395 THE COURT:

Overruled.

396 MR. YAMAUCHI:

No. I don't--

397 MR. SCHECK:

I'm sorry.

398 MR. YAMAUCHI:

I don't remember whether he was there or not.

399 MR. SCHECK:

See if I can refresh your recollection. Do you remember him having any discussions with Mr. Matheson?

400 MR. HARMON:

Objection. Asked and answered.

401 THE COURT:

Overruled.

402 MR. YAMAUCHI:

I don't remember.

403 MR. SCHECK:

Do you remember seeing Detective Lange engaged in any conversations with Mr. Fung?

404 MR. YAMAUCHI:

I--I've--I can recall him talking to Mr. Fung on certain occasions, but I don't know specifically of that day I saw them talking or if they were there. I--my recollection isn't all that great.

405 THE COURT:

Let's move on.

406 MR. SCHECK:

On the morning of June 14th, you recall speaking first about this case with Mr. Matheson?

407 MR. YAMAUCHI:

Yes.

408 MR. SCHECK:

And your recollection now is that Mr. Fung was not present at that conversation?

409 MR. YAMAUCHI:

Yes. I remember him telling me to go see Dennis, discuss samples.

410 MR. SCHECK:

I'm asking you whether Mr. Fung was present at the time that you were speaking with Mr. Matheson first thing in the morning.

411 MR. YAMAUCHI:

I don't remember.

412 MR. HARMON:

Objection. "First thing in the morning" is vague.

413 THE COURT:

Overruled.

414 MR. SCHECK:

And have you reviewed Mr. Matheson's notes as to the chronology of events on the morning of June 14th?

415 MR. YAMAUCHI:

No.

416 MR. SCHECK:

Prosecutors shown you or told you about his notes with respect to the chronology of events on June 14th?

417 MR. HARMON:

Objection. Asked and answered. Calls for hearsay.

418 THE COURT:

Overruled.

419 MR. YAMAUCHI:

No.

420 MR. SCHECK:

Have you discussed with Mr. Matheson at any time prior to coming in here and testifying the chronology of events on the morning of June 14th?

421 MR. YAMAUCHI:

No.

422 MR. SCHECK:

Did you watch Mr. Matheson testify or hear him testify about the chronology of events on June 14th?

423 MR. YAMAUCHI:

I saw a lot of his testimony, but I don't remember that.

424 MR. SCHECK:

Did you watch Mr. Fung's testimony with respect to the chronology of events on the morning of June 14th?

425 MR. YAMAUCHI:

Yes.

426 MR. SCHECK:

Did you watch Miss Mazzola's testimony with respect to the chronology of events on the morning of June 14th?

427 MR. YAMAUCHI:

No.

428 MR. SCHECK:

Now, in your first conversation with Mr. Matheson on the morning of June 14th, were you not told that the detectives were in a hurry to get DNA testing results?

429 MR. HARMON:

Objection. Calls for hearsay.

430 THE COURT:

Overruled.

431 MR. YAMAUCHI:

They needed information from the laboratory. I don't remember anybody talking specifically DNA.

432 MR. SCHECK:

Well, when you had a conversation with Mr. Matheson on the morning of June 14th, were you not informed that you were supposed to be doing DNA testing?

433 MR. YAMAUCHI:

No. Actually, he discussed potential conventional testing and said that what they needed was something that could be--act as kind of a screen, something that could possibly eliminate somebody quickly or possibly include somebody.

434 MR. SCHECK:

Did you reach a decision early in the morning with Mr. Matheson to conduct DNA testing, PCR DNA testing?

435 MR. YAMAUCHI:

I told him I thought that PCR DQ-Alpha would be the best for that purpose.

436 MR. SCHECK:

And you were told--well, withdrawn. Did you and Mr. Matheson discuss the need to do that PCR DNA testing very quickly?

437 MR. YAMAUCHI:

Well, yes. There was mention that the results were very important to them, and as soon as possible, they would need them.

438 MR. SCHECK:

Who's the "Them"?

439 MR. YAMAUCHI:

That--

440 MR. HARMON:

Objection. Calls for speculation. It's hearsay.

441 THE COURT:

Rephrase the question.

442 MR. SCHECK:

You just said "Them," "Important to them." Who did you mean by "Them"?

443 MR. YAMAUCHI:

The investigating officers.

444 MR. SCHECK:

Detective Lange?

445 MR. YAMAUCHI:

I'm not real sure if at that point, I knew who the investigating officers were.

446 MR. SCHECK:

Were you told by Mr. Matheson that the investigating officers wanted these results in a hurry?

447 MR. YAMAUCHI:

They put a lot of importance on it. I don't know if anybody used the word hurry.

448 MR. SCHECK:

On direct examination, I think you used the words "Very quickly."

449 MR. YAMAUCHI:

I might have.

450 MR. SCHECK:

Would it be fair to say that this was sort of conveyed to you that this was what might be called a rush job?

451 MR. HARMON:

Objection. It calls for speculation.

452 THE COURT:

Overruled.

453 MR. HARMON:

It's also argumentative.

454 THE COURT:

Do you know what a rush job is?

455 MR. YAMAUCHI:

Considering the importance--yes. Well--in a certain expect like well, if you're working on something else, could you work on this case right now.

456 MR. SCHECK:

Drop everything else and do this as fast as humanly possible. Is that the impression you got?

457 MR. HARMON:

Objection. That's argumentative.

458 THE COURT:

Overruled.

459 MR. YAMAUCHI:

As fast as humanly possible? Well, more like within the perimeters of the scientific technology and the technique.

460 MR. SCHECK:

And you then had conversations with Mr. Fung that morning?

461 MR. YAMAUCHI:

Yes.

462 MR. SCHECK:

In the evidence processing room?

463 MR. YAMAUCHI:

Yes.

464 MR. SCHECK:

And he described the evidence to you?

465 MR. YAMAUCHI:

Yes.

466 MR. SCHECK:

And he told you about information that he had obtained from the detectives at robbery-homicide?

467 MR. YAMAUCHI:

Yes.

468 MR. SCHECK:

And he told you that it was important to get DNA typing results on the Bundy blood drops fast?

469 MR. YAMAUCHI:

No.

470 MR. SCHECK:

As soon as possible?

471 MR. YAMAUCHI:

I don't really remember.

472 MR. SCHECK:

Quickly?

473 MR. YAMAUCHI:

I don't recall if Dennis told me anything like that or not.

474 THE COURT:

All right. Mr. Yamauchi, were you under the impression this was a priority matter?

KEY QUOTE
475 MR. YAMAUCHI:

Yes.

476 THE COURT:

All right.

477 MR. YAMAUCHI:

That's the bottom line.

KEY QUOTE
478 THE COURT:

I think we've established that.

479 MR. SCHECK:

Were you told to get DNA results as soon as you could on the glove recovered from Rockingham?

480 MR. YAMAUCHI:

I think to speed things up, the whole thing was kind of like a priority matter.

481 MR. SCHECK:

Were you told by anyone in the laboratory on June 14th--withdrawn. Did Greg Matheson tell you on the morning of June 14th, "Mr. Yamauchi, don't be in a rush here. Just be careful"?

482 THE COURT:

It's argumentative, counsel.

483 MR. SCHECK:

Did he tell you to be careful and make sure you didn't do these tests too quickly? Did he say that?

484 MR. YAMAUCHI:

Nobody gave me any deadlines as to, "We want you to have results by here, here, here," or anything like that. There was a priority put on it. And if anything, Greg would have told me to work within my own perimeters of what I know is possible and to--above all, it's--for all of us as criminalists, make sure you do a good job.

485 MR. SCHECK:

Mr. Yamauchi, my question to you is not what he would have told you. I'm asking you, to the best of your recollection, what he did tell you. Did he tell you to be careful and take your time to get it right?

486 MR. HARMON:

Objection. Asked and answered. Argumentative.

487 THE COURT:

Sustained. We've spent enough time on this.

488 MR. SCHECK:

Last point that I think is new.

489 THE COURT:

Better be.

490 MR. SCHECK:

It is.

491 MR. SCHECK:

Did anybody tell you to get DNA results on the Bundy blood drops and the glove within one day?

492 MR. YAMAUCHI:

No.

493 MR. SCHECK:

That was your idea?

494 THE COURT:

It's argumentative, counsel.

495 MR. SCHECK:

Was that your idea?

496 MR. YAMAUCHI:

Well, I knew if I worked after hours, I could complete the process. So yes, that was my idea.

497 MR. SCHECK:

So at the beginning of the morning, you had set a goal for yourself that you would be able to process the Bundy blood drops and the glove in one day?

498 MR. HARMON:

Objection. It's argumentative, misstates his testimony.

499 THE COURT:

Overruled.

500 MR. YAMAUCHI:

Well, I knew that I would have some kind of interpretable results by that time period. But the whole process wouldn't have been complete. There still would have been product gel that would have had to have been done at a later point.

501 MR. SCHECK:

Did you set a goal for yourself that you would be able to get typing results off the strips on the Bundy blood drops and the glove in one day?

502 MR. YAMAUCHI:

Yes. That was my intention.

503 MR. SCHECK:

And that was a goal you set for yourself and nobody else told you to do it within that deadline?

504 MR. YAMAUCHI:

It wasn't like it was a goal or anything. I--I knew that if I worked beyond normal working hours, I would have enough time to do that in the same fashion I always do it.

505 MR. SCHECK:

Now, before going through you--withdrawn. Before going through with you what you did on the morning of June 14th step by step, I'd like to just review with you what you did as a whole, okay? On June 14th, you received the specimens from the Bundy blood drops--withdrawn. On June 14th, you received specimens, completed PCR amplification and obtained results in one day on 23 samples?

506 MR. YAMAUCHI:

Can I refer to my notes?

507 MR. SCHECK:

Yes.

508 MR. YAMAUCHI:

Okay.

509 MR. SCHECK:

And refer you to your amplification records and hybridization records. One day, 23 samples.

510 (Brief pause.)
511 MR. YAMAUCHI:

I did 19.

512 MR. SCHECK:

I'm talking about June the 14th.

513 MR. YAMAUCHI:

Yes. I analyzed 19 casework samples.

514 MR. SCHECK:

Can I take a look at those?

515 (Brief pause.)
516 MR. YAMAUCHI:

That's what you're talking about, right?

517 MR. SCHECK:

I'm asking you to look at your DNA amplification and hybridization sheets. I'm talking about the specimens, the controls, the reference samples, all that's involved in doing a PCR amplification run. Didn't you create 23 separate samples and tubes to analyze on June 14th before you reported results?

518 MR. YAMAUCHI:

Yeah. It would be 23.

519 MR. SCHECK:

23. Yes?

520 MR. YAMAUCHI:

Let me check for sure, but that sounds correct. (Brief pause.)

521 MR. YAMAUCHI:

Yes.

522 MR. SCHECK:

And on June 15th, the next day, you received specimens--withdrawn. And just so we're clear, the evidence items involved on June 14th were the Bundy blood drops, items 47, 48, 49, 50 and 52, correct?

523 MR. YAMAUCHI:

Yes.

524 MR. SCHECK:

Two what you're calling exemplars, that is, bloodstains that were believed to come from both victims in this case?

525 MR. YAMAUCHI:

Well, at that point in time, there were no exemplars available. So--

526 MR. SCHECK:

What I mean by exemplar, sir, is that you were given two bloodstains, one--

527 MR. HARMON:

Your Honor, objection. He cut off his answer there. He wasn't done.

528 MR. SCHECK:

I'm just trying to clarify, your Honor.

529 MR. HARMON:

He still cut him off.

530 THE COURT:

Proceed.

531 MR. SCHECK:

You received a bloodstain that Mr. Fung told you was believed to be an exemplar or blood from Nicole Brown Simpson?

532 MR. YAMAUCHI:

Well, because we didn't have exemplars at the time, that was to act in lieu of it, to give any possible information it might.

533 MR. SCHECK:

Yes. And so you even put down in your notes you were using it as an exemplar for Miss Nicole Brown Simpson on June 14th?

534 MR. YAMAUCHI:

Let me check my notes.

535 (Brief pause.)
536 MR. YAMAUCHI:

Well, no. Actually my notes specifically state, "Male victim, exemplar off tree stump, female, best sample exemplar, concrete," and then in bracket, "These samples not true exemplars."

537 MR. SCHECK:

They're not true exemplars because they're not actually blood from the Coroner's office, right?

538 MR. YAMAUCHI:

Right. Because we didn't have it at that time.

539 MR. SCHECK:

Right. But as far as you were concerned, you were taking these two samples because Mr. Fung told you that they felt certain that the blood on one of those items could be used as an exemplar for Miss Nicole Brown Simpson because--is that right?

540 MR. HARMON:

Objection. That's compound, calls for speculation, hearsay.

541 THE COURT:

Overruled.

542 MR. YAMAUCHI:

I'm sorry. Could you please start over again?

543 MR. SCHECK:

You told--

544 THE COURT:

Counsel, wait. He read his notes. It's used in place of an exemplar. The jury's heard the testimony. Let's move on.

545 MR. SCHECK:

Well, you knew that these two exemplars were sam--being used as samples from the victims?

546 MR. YAMAUCHI:

Well, until we got the real exemplars, yes, that was their purpose, to act in that--on behalf of what would be the best possible exemplar.

547 MR. SCHECK:

And that was being done at the same time as the Bundy blood drops on June 14th?

548 MR. HARMON:

Objection. "Being done at the same time" is vague.

549 THE COURT:

Overruled.

550 MR. SCHECK:

That was part of your 23 samples?

551 MR. YAMAUCHI:

It was in that group, yes.

552 MR. SCHECK:

And also within those 23 samples was blood from the reference tube of Mr. Simpson?

553 MR. YAMAUCHI:

Yes.

554 MR. SCHECK:

Now, on June 15th, you received specimens, completed PCR amplification and obtained results on 19 different samples?

555 MR. YAMAUCHI:

Yes. On the 15th, counting the controls and everything, 19.

556 MR. SCHECK:

And you did all those in one day, June 15th?

557 MR. YAMAUCHI:

Yes. I got through the hybridization step in that time period.

558 MR. SCHECK:

You received the samples, you cut them, you did PCR extraction and you did typing on the strip so that you could report results by the end of the day on all 19 of those?

559 MR. YAMAUCHI:

Well, I couldn't report the results till all the other things were in place and everything was looked at and written out. But I would have results available for interpretation.

560 MR. SCHECK:

The evening of June 15th, you called Greg Matheson and gave him results on those 19 samples based on the PCR typing strips?

561 MR. YAMAUCHI:

Yes. I told him what I got up to that poison.

562 MR. SCHECK:

The only thing that was missing, as far as the way you did this, was the PCR product gel, right?

563 MR. YAMAUCHI:

Yes.

564 MR. SCHECK:

Now, was it part of your training to avoid analyzing a large number of samples in a short period of time because that can increase the chance of inadvertent cross-contamination and mix up?

565 MR. YAMAUCHI:

Well, if you're referring to this case, I didn't do it in a short period of time. I did it in--

566 MR. SCHECK:

Mr. Yamauchi--

567 MR. YAMAUCHI:

--quite a big block of time.

568 THE COURT:

Wait, wait. No. You don't get to cut off the answer.

569 MR. SCHECK:

Move to strike. Nonresponsive.

570 THE COURT:

Overruled. Let him finish the answer.

571 MR. YAMAUCHI:

Yes, because I went way beyond what a normal workday is in order to complete those steps.

572 MR. SCHECK:

Move to strike, not responsive. I asked him about his training, only his training.

573 THE COURT:

You're asking about the short period. Overruled. Proceed. Proceed.

574 MR. SCHECK:

In your training, were you taught to avoid analyzing a large number of samples in a short period of time because that can increase the chance of inadvertent cross-contamination and mix-up?

575 MR. YAMAUCHI:

You know, I don't know in those words if that was ever said to me.

576 MR. SCHECK:

Are you familiar with the amplitype user guide?

577 THE COURT:

Why don't you just ask him if he agrees with that concept.

578 MR. SCHECK:

No. I would like to show him the actual user guide. He said he didn't have anything in his training.

579 THE COURT:

We're talking about common sense things here and we're spending a lot of time on it.

580 MR. SCHECK:

Your Honor, we are talking about basic points of training. That's correct.

581 THE COURT:

All right. So let's proceed.

582 MR. SCHECK:

We're trying to establish with the witness what a basic point of training is.

583 THE COURT:

Proceed. Proceed.

584 MR. SCHECK:

Did you review in the amplitype user guide--withdrawn. In your training, did you review special precautions that are included in the amplitype user guide?

585 MR. YAMAUCHI:

Yes. I've read through that entire user guide.

586 MR. SCHECK:

And you studied it?

587 MR. YAMAUCHI:

Yes.

588 THE COURT:

And you rely upon it.

589 MR. YAMAUCHI:

Well, that along with another book, which would be our own protocol and procedure manual, and a lot of other journal articles and experience to make up my opinions, if that's what you're asking.

590 MR. SCHECK:

Okay. May I approach the witness?

591 THE COURT:

You may.

592 MR. HARMON:

May I see that section?

593 THE COURT:

Counsel, I assume you have that as well. Proceed.

594 MR. SCHECK:

And you're familiar with the section of the user guide entitled "Special precautions"?

595 MR. YAMAUCHI:

Yes.

596 MR. SCHECK:

And are familiar with paragraph 14 of the section on "Special precautions"?

597 MR. YAMAUCHI:

Yes.

598 MR. SCHECK:

And do you rely on that paragraph?

599 MR. YAMAUCHI:

Yes. I would agree with that.

600 MR. SCHECK:

And does not that paragraph state that you should limit the quantity of samples handled in a single run to a manageable number, approximately 15, "This precaution will reduce the risk of sample mix up and the potential for sample-to-sample contamination"?

601 MR. YAMAUCHI:

Yes. And I think 23 is a reasonably close number to 15.

KEY QUOTE
602 MR. SCHECK:

You do?

603 MR. YAMAUCHI:

Yes, I do.

604 MR. SCHECK:

It's two minutes.

605 THE COURT:

All right. Ladies and gentlemen, we are going to take our recess for the morning session. Please remember all of my admonitions to you; do not discuss this case amongst yourselves, do not form any opinions about the case, do not allow anybody to communicate with you with regard to the case, do not conduct any deliberations until the matter has been submitted to you. As far as the jury is concerned, we will stand in recess until Monday morning at 10:00 A.M.--Tuesday morning 10:00 A.M. and I want counsel here at 9:00 A.M. all right. We'll stand in recess. Ladies and gentlemen, have a pleasant weekend. Mr. Yamauchi, you are excused, ordered to come back 8:45 on Tuesday. Enjoy your activities. All right.

Temperature

tense

Key Quotes (5)

Collin Yamauchi
Yes. And I think 23 is a reasonably close number to 15.
Yamauchi defends processing 23 samples in one day when the Amplitype user guide specifically recommends limiting runs to approximately 15 to reduce contamination risk — a damaging admission undermining his claim of careful methodology.
Lance A. Ito
Mr. Yamauchi, were you under the impression this was a priority matter? ... All right.
The judge himself elicited the clearest admission that Yamauchi treated this as a rush job, after Scheck spent considerable time circling the point.
Collin Yamauchi
Yes. That's the bottom line.
Yamauchi directly confirms to Judge Ito that the Simpson DNA analysis was a 'priority matter,' supporting the defense's argument that police pressure compromised careful analysis.
Collin Yamauchi
Well, I knew that if I worked beyond normal working hours, I would have enough time to do that in the same fashion I always do it.
Yamauchi claims staying late preserved scientific rigor, but Scheck uses this to show he self-imposed a one-day deadline that the defense argues was unreasonably ambitious.
Collin Yamauchi
No. I never did.
Yamauchi admits he received no training about false positives arising when degraded samples are analyzed alongside a suspect's reference blood — directly relevant to the defense's contamination theory.

Evidence (5)

Defense 1182
Hybridization record from a CAP (College of American Pathologists) external proficiency test, showing Yamauchi as analyst and Erin Reilly as confirming analyst — used to demonstrate non-blind testing procedures
introduced and discussed
Informal
Amplitype user guide, 'Special Precautions' section, paragraph 14 — recommending a limit of approximately 15 samples per run to reduce mix-up and contamination risk
discussed
Informal
NRC report: 'DNA Technology in Forensic Science,' particularly the section on laboratory error rates at page 88
discussed; Yamauchi stated he did not rely on the error rate section
Informal
Bundy blood drop items 47, 48, 49, 50, and 52, plus victim exemplar samples and OJ Simpson reference blood tube — the 23 samples processed on June 14th
discussed
Informal
CACLD (California Association of Crime Lab Directors) external proficiency test reports from 1988-1989, involving false positives at cellmark and forensic science associates
referenced; Yamauchi denied awareness during training

Notable Exchanges (5)

Barry ScheckCollin Yamauchi
Scheck catches himself omitting 'approximately' from the protocol's six-month training requirement, but Yamauchi had already caught it — leading to an awkward back-and-forth about whether Yamauchi's initial failure to recall the provision was because Scheck misread it.
strategic
Lance A. ItoCollin Yamauchi
After Scheck spent many questions circling the 'rush' question, Ito directly asked Yamauchi if he understood this was a priority matter and got a crisp 'Yes. That's the bottom line,' then told Scheck 'I think we've established that.'
revealing
Barry ScheckCollin Yamauchi
Scheck establishes that Erin Reilly had more PCR experience and Harry Klan had more RFLP experience than Yamauchi, yet Yamauchi was assigned to the highest-profile case in the lab's history.
strategic
Barry ScheckCollin Yamauchi
Scheck walks Yamauchi through the proficiency test structure, establishing that he and Erin Reilly served as each other's confirming analysts on the same test — meaning each could know the other's answers before submitting their own results.
revealing
Barry ScheckCollin Yamauchi
Scheck confronts Yamauchi with the Amplitype user guide's recommendation to limit samples to ~15 per run; Yamauchi responds that '23 is a reasonably close number to 15,' drawing an incredulous 'You do?' from Scheck.
devastating

Light Moments (2)

Lance A. Ito
An audience outburst prompted Judge Ito to interrupt with five consecutive 'Excuse me' repetitions, then scold the gallery: 'This is not an audience participation enterprise here, folks. You're here as an audience, not as participants.'
Lance A. Ito
When Scheck pushed Yamauchi on whether he gestured dismissively at the witness, Ito noted: 'Mr. Scheck, that kind of gesture is not required.' Scheck apologized.

Credibility Attacks (5)

⚔ Collin Yamauchi
qualification challenge
Scheck established Yamauchi was not the most experienced DNA analyst in the lab — Erin Reilly had more PCR experience and Harry Klan had more RFLP experience — yet he was assigned the Simpson case.
⚔ Collin Yamauchi
protocol violation
Scheck used the Amplitype user guide's own 'Special Precautions' to show Yamauchi processed 23 samples in a single run against a guideline of approximately 15, increasing contamination and mix-up risk.
⚔ Collin Yamauchi
proficiency testing irregularity
Scheck demonstrated that Yamauchi and Reilly served as each other's confirming analysts on the same proficiency tests, meaning neither was truly 'blind' to the other's results — undermining the independence and integrity of those tests.
⚔ Collin Yamauchi
inadequate training
Yamauchi admitted he was unaware of false positives at forensic science associates (a PCR lab) during CACLD proficiency tests, had never taken a true double-blind external proficiency test, and could not recall which scientific journals he read regularly.
⚔ Collin Yamauchi
bias / rush job
Scheck established that Yamauchi processed 42 samples over two days under intense police pressure he described as a 'priority matter,' with no one explicitly telling him to slow down and be careful.

Witness Demeanor

Repeatedly cautious and hedging ('I'd have to check the records,' 'approximately')
Occasionally evasive or deflecting ('Could you define that?', 'I want to know if we're on the same wavelength')
Caught off-guard when Ito himself asked the dispositive question about priority
Defended his 23-sample run confidently despite the user guide's 15-sample guidance

Objections

38 objections (16 sustained, 22 overruled)
Proceeding 6198 • 605 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 26, 1995 📄 Cross-examination of Collin Ya
MAY 26, 1995 KRT DvH TD